|
Market Closed -
Nasdaq
21:00:00 12/02/2026 GMT
|
After hours
21:29:16
|
|
151.81 USD
|
-2.56%
|
 |
153.24 |
+0.95%
|
|
01-29 |
Gilead Sciences Insider Sold Shares Worth $1,398,911, According to a Recent SEC Filing
|
MT
| |
01-27 |
Gilead Sciences Insider Sold Shares Worth $15,611,400, According to a Recent SEC Filing
|
MT
| |
01-26 |
Janux Therapeutics, Inc. Announces Chief Medical Officer Changes
|
CI
| |
01-21 |
Gilead Sciences Insider Sold Shares Worth $617,500, According to a Recent SEC Filing
|
MT
| |
01-12 |
Kyverna Therapeutics, Inc. Appoints Christi Shaw as Executive Chairperson of the Board, Effective January 12, 2026
|
CI
| |
01-05 |
Tango Therapeutics, Inc. Appoints Sung Lee to its Board of Directors
|
CI
| |
12-18 |
Cartesian Therapeutics, Inc. Announces the Appointment of Adrian Bot to Board of Directors and Member of the Science and Technology Committee
|
CI
| |
12-18 |
Gilead Sciences, Inc. Appoints Keeley Wettan as Executive Vice President, General Counsel, Legal & Compliance Effective December 18, 2025
|
CI
| |
12-16 |
Pliant Therapeutics, Inc. Appoints Minnie Kuo as Chief Operating Officer, Effective December 10, 2025
|
CI
| |
12-03 |
Soleno Therapeutics, Inc. Announces Demise of William G. Harris, Member of Board of Directors and Audit Committee Changes
|
CI
| |
11-26 |
Vera Therapeutics, Inc. Appoints James R. Meyers to Its Board of Directors
|
CI
| |
11-19 |
Gilead says Deborah Telman to step down as evp at Gilead Sciences - SEC filing
|
RE
| |
11-19 |
Deborah H. Telman to No Longer Serve as Executive Vice President, Corporate Affairs and General Counsel of Gilead Sciences, Inc. as of December 5, 2025
|
CI
| |
11-19 |
Gilead Sciences Insider Sold Shares Worth $3,524,173, According to a Recent SEC Filing
|
MT
| |
11-14 |
Cytokinetics, Incorporated Appoints Jeffrey J. Hessekiel as Executive Vice President, Chief Legal and Administrative Officer, Effective as of November 14, 2025
|
CI
| |
11-14 |
Gilead Sciences Insider Sold Shares Worth $6,590,487, According to a Recent SEC Filing
|
MT
| |
11-10 |
Nurix Therapeutics, Inc. Appoints Roger Dansey to Its Board of Directors
|
CI
| |
11-07 |
Immuthera and Its Wholly Owned Subsidiary of Poltreg S.A Appoints Adrian Bot to Its Board of Directors
|
CI
| |
11-03 |
Prime Medicine, Inc. Appoints Matthew Hawryluk as Chief Business Officer
|
CI
| |
31/10/25 |
Galapagos NV Announces Board Changes, Effective November 1, 2025
|
CI
| |
29/10/25 |
Gilead Sciences Insider Sold Shares Worth $1,193,926, According to a Recent SEC Filing
|
MT
| |
28/10/25 |
Jazz Pharmaceuticals plc Announces Board Changes, Effective December 1, 2025
|
CI
| |
30/09/25 |
Gilead Sciences Insider Sold Shares Worth $1,116,564, According to a Recent SEC Filing
|
MT
| |
16/09/25 |
Gilead Sciences Insider Sold Shares Worth $340,710, According to a Recent SEC Filing
|
MT
| |
16/09/25 |
Gilead Sciences Insider Sold Shares Worth $283,925, According to a Recent SEC Filing
|
MT
|
No results for this search Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
